FDA warning letter

FDA
Marketing

ImmunityBio hit with FDA warning letter over Anktiva promotions

The FDA issued a warning letter to ImmunityBio regarding promotional statements about Anktiva that the agency claims are “false or misleading.”
Andrea Park Mar 24, 2026 1:15pm
FDA

Strides recalls children's pain meds due to contamination

Mar 24, 2026 8:52am
FDA stop sign

FDA scolds Simtra with warning letter for contamination issues

Mar 13, 2026 11:00am
Novo Nordisk

Novo's US headquarters hit with FDA warning letter

Mar 10, 2026 11:40am
FDA

Indian API maker Cdymax hit with warning letter tied to testing

Nov 20, 2025 9:27am
Nephron Pharma

Nephron dinged again by FDA for ongoing manufacturing issues

Oct 23, 2025 8:25am